Scott Biller

Google Ventures is an investment arm of Alphabet that provides seed, venture, and growth-stage funding to technology companies.

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.

Raised $199,000,000.00 from Mass General Brigham Ventures, Casdin Capital, Section 32, Curie.Bio, Sanofi Ventures, Google Ventures, Mirae Asset Capital, Luma Group, Axon Ventures and Andreessen Horowitz.

Gate Bioscience specializes in a small molecule modality to treat biology’s intractable diseases.

Raised $60,000,000.00 from Google Ventures, Versant Ventures, ARCH Venture Partners and Andreessen Horowitz.

Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.

Raised $211,000,000.00 from Surveyor Capital, The Column Group, Atlas Venture, Alexandria Venture Investments, Casdin Capital, ARCH Venture Partners, Foresite Capital, WTT Investment and Willett Advisors LLC.

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

Raised $221,000,000.00 from Irving Investors, Invus, Casdin Capital and Flagship Pioneering.

Agios Pharmaceuticals is a biopharmaceutical company discovers and develops therapeutics in the field of cancer metabolism.

Raised $775,823,937.00 from Celgene, Flagship Pioneering, ARCH Venture Partners and Third Rock Ventures.

Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.

Raised $1,122,000,000.00 from Baillie Gifford, ARCH Venture Partners, F-Prime Capital, Flagship Pioneering and Alaska Permanent Fund.